4//SEC Filing
ROBIN HOWARD W 4
Accession 0000950170-25-025035
CIK 0000906709other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 6:04 PM ET
Size
6.0 KB
Accession
0000950170-25-025035
Insider Transaction Report
Form 4
ROBIN HOWARD W
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2025-02-19$1.01/sh−23,774$24,012→ 1,086,901 total
Holdings
- 410(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001206869
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 6:04 PM ET
- Size
- 6.0 KB